Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 84-93, April 2010

Adaptive Radiotherapy of Head and Neck Cancer

Department of Radiation Oncology, Center for Molecular Imaging and Experimental Radiotherapy (IMRE), Université catholique de Louvain, St-Luc University Hospital, Brussels, Belgium

Intensity-modulated radiation therapy (IMRT) in head and neck (H&N) cancer has the capability to generate steep dose gradients, leading to an improved therapeutic index. IMRT plans are typically based on a pretreatment computed tomography scan that provides a snapshot of the patient's anatomy. Nevertheless, interfractional patient variations may occur because of setup error and anatomical modifications. Therefore, the accuracy of IMRT delivery for H&N cancer may be compromised during the treatment course, potentially affecting the therapeutic index. In this framework, adaptive radiotherapy is a potential solution, which consists of “the explicit inclusion of the temporal changes in anatomy during the imaging, planning, and delivery of radiotherapy.” Adaptive radiotherapy has brought an additional dimension to the management of patients with H&N cancer and has the potential to counteract the effects of positioning errors and anatomical changes. This article reviews the causes and discusses potential solutions to circumvent the discrepancies between the planned dose and the actual dose received by patients treated for H&N malignancies.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work is supported by a grant from the Belgian Federation against Cancer (convention Number SCIE 2003-23FR), by a grant from the “Cancéropôle du Nord-Ouest (France),” by a grant (Painter) from the Région wallonne (Belgium), by the “Fonds J. Maisin” of the Université catholique de Louvain and by grants from the European Community (Biocare EC Research Program # LSHC-CT-2004-505785; Maestro EC project # LSHC-CT-2004-503564).

 The authors have no financial relationship with the organizations that sponsored the research.

 John A. Lee and Xavier Geets are postdoctoral fellows with the FNRS (Fonds National de la Recherche Scientifique).

 Financial support: Pierre Castadot is a research fellow with the FNRS (Fonds National de la recherche Scientifique).

PII: S1053-4296(09)00076-9

doi:10.1016/j.semradonc.2009.11.002

Seminars in Radiation Oncology
Volume 20, Issue 2 , Pages 84-93, April 2010